Annual Total Liabilities
$29.02 M
+$1.07 M+3.84%
December 31, 2023
Summary
- As of February 8, 2025, WINT annual total liabilities is $29.02 million, with the most recent change of +$1.07 million (+3.84%) on December 31, 2023.
- During the last 3 years, WINT annual total liabilities has fallen by -$14.32 million (-33.04%).
- WINT annual total liabilities is now -43.42% below its all-time high of $51.28 million, reached on December 31, 2018.
Performance
WINT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$26.04 M
+$826.00 K+3.28%
September 30, 2024
Summary
- As of February 8, 2025, WINT quarterly total liabilities is $26.04 million, with the most recent change of +$826.00 thousand (+3.28%) on September 30, 2024.
- Over the past year, WINT quarterly total liabilities has dropped by -$2.53 million (-8.87%).
- WINT quarterly total liabilities is now -49.23% below its all-time high of $51.28 million, reached on December 31, 2018.
Performance
WINT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
WINT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.8% | -8.9% |
| 3 y3 years | -33.0% | -7.5% |
| 5 y5 years | -43.4% | -7.5% |
WINT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.8% | +3.8% | -20.9% | +77.3% |
| 5 y | 5-year | -34.1% | +3.8% | -42.0% | +77.3% |
| alltime | all time | -43.4% | +9571.7% | -49.2% | +8579.7% |
Windtree Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.04 M(+3.3%) |
| Jun 2024 | - | $25.21 M(+71.7%) |
| Mar 2024 | - | $14.68 M(-49.4%) |
| Dec 2023 | $29.02 M(+3.8%) | $29.02 M(+1.5%) |
| Sep 2023 | - | $28.57 M(-1.4%) |
| Jun 2023 | - | $28.97 M(+2.9%) |
| Mar 2023 | - | $28.16 M(+0.8%) |
| Dec 2022 | $27.94 M(-15.1%) | $27.94 M(-8.9%) |
| Sep 2022 | - | $30.68 M(-5.9%) |
| Jun 2022 | - | $32.62 M(+0.7%) |
| Mar 2022 | - | $32.38 M(-1.6%) |
| Dec 2021 | $32.91 M(-24.1%) | $32.91 M(-5.0%) |
| Sep 2021 | - | $34.65 M(+1.6%) |
| Jun 2021 | - | $34.10 M(-23.2%) |
| Mar 2021 | - | $44.41 M(+2.5%) |
| Dec 2020 | $43.33 M(-1.6%) | $43.33 M(+1.2%) |
| Sep 2020 | - | $42.81 M(-4.6%) |
| Jun 2020 | - | $44.87 M(+4.6%) |
| Mar 2020 | - | $42.90 M(-2.6%) |
| Dec 2019 | $44.04 M(-14.1%) | $44.04 M(-7.4%) |
| Sep 2019 | - | $47.56 M(+1.2%) |
| Jun 2019 | - | $46.98 M(-3.4%) |
| Mar 2019 | - | $48.63 M(-5.2%) |
| Dec 2018 | $51.28 M(+88.1%) | $51.28 M(+54.1%) |
| Sep 2018 | - | $33.28 M(+9.6%) |
| Jun 2018 | - | $30.36 M(-2.2%) |
| Mar 2018 | - | $31.03 M(+13.8%) |
| Dec 2017 | $27.27 M(-29.2%) | $27.27 M(-35.2%) |
| Sep 2017 | - | $42.10 M(+10.8%) |
| Jun 2017 | - | $38.01 M(+1.4%) |
| Mar 2017 | - | $37.47 M(-2.8%) |
| Dec 2016 | $38.53 M(+6.7%) | $38.53 M(-1.9%) |
| Sep 2016 | - | $39.28 M(-2.3%) |
| Jun 2016 | - | $40.22 M(+1.3%) |
| Mar 2016 | - | $39.69 M(+9.9%) |
| Dec 2015 | $36.11 M(+27.6%) | $36.11 M(+3.6%) |
| Sep 2015 | - | $34.84 M(+11.4%) |
| Jun 2015 | - | $31.28 M(+3.2%) |
| Mar 2015 | - | $30.31 M(+7.1%) |
| Dec 2014 | $28.30 M(-8.2%) | $28.30 M(-3.6%) |
| Sep 2014 | - | $29.34 M(-3.1%) |
| Jun 2014 | - | $30.27 M(-1.4%) |
| Mar 2014 | - | $30.69 M(-0.4%) |
| Dec 2013 | $30.82 M(+150.7%) | $30.82 M(+69.7%) |
| Sep 2013 | - | $18.16 M(+6.2%) |
| Jun 2013 | - | $17.09 M(-13.3%) |
| Mar 2013 | - | $19.70 M(+60.3%) |
| Dec 2012 | $12.29 M(+1.9%) | $12.29 M(-26.4%) |
| Sep 2012 | - | $16.70 M(+23.9%) |
| Jun 2012 | - | $13.48 M(-13.1%) |
| Mar 2012 | - | $15.51 M(+28.6%) |
| Dec 2011 | $12.06 M(+41.7%) | $12.06 M(-13.8%) |
| Sep 2011 | - | $13.99 M(-12.8%) |
| Jun 2011 | - | $16.04 M(+8.3%) |
| Mar 2011 | - | $14.81 M(+74.1%) |
| Dec 2010 | $8.51 M(-57.7%) | $8.51 M(-7.5%) |
| Sep 2010 | - | $9.20 M(-11.2%) |
| Jun 2010 | - | $10.35 M(-38.3%) |
| Mar 2010 | - | $16.77 M(-16.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $20.11 M(-8.4%) | $20.11 M(+10.6%) |
| Sep 2009 | - | $18.18 M(-4.2%) |
| Jun 2009 | - | $18.98 M(-8.9%) |
| Mar 2009 | - | $20.83 M(-5.1%) |
| Dec 2008 | $21.96 M(-8.4%) | $21.96 M(-6.5%) |
| Sep 2008 | - | $23.49 M(+0.8%) |
| Jun 2008 | - | $23.30 M(+4.1%) |
| Mar 2008 | - | $22.38 M(-6.6%) |
| Dec 2007 | $23.96 M(+19.3%) | $23.96 M(+8.5%) |
| Sep 2007 | - | $22.08 M(+6.9%) |
| Jun 2007 | - | $20.66 M(+9.2%) |
| Mar 2007 | - | $18.93 M(-5.7%) |
| Dec 2006 | $20.08 M(-5.2%) | $20.08 M(-3.4%) |
| Sep 2006 | - | $20.78 M(-3.6%) |
| Jun 2006 | - | $21.55 M(-0.3%) |
| Mar 2006 | - | $21.61 M(+2.1%) |
| Dec 2005 | $21.17 M(+28.0%) | $21.17 M(+17.7%) |
| Sep 2005 | - | $17.99 M(+0.9%) |
| Jun 2005 | - | $17.83 M(+3.1%) |
| Mar 2005 | - | $17.29 M(+4.5%) |
| Dec 2004 | $16.54 M(+96.6%) | $16.54 M(+36.2%) |
| Sep 2004 | - | $12.15 M(+4.6%) |
| Jun 2004 | - | $11.61 M(+22.9%) |
| Mar 2004 | - | $9.45 M(+12.3%) |
| Dec 2003 | $8.41 M(+33.5%) | $8.41 M(+14.4%) |
| Sep 2003 | - | $7.35 M(+22.4%) |
| Jun 2003 | - | $6.00 M(-0.1%) |
| Mar 2003 | - | $6.01 M(-4.6%) |
| Dec 2002 | $6.30 M(+158.0%) | $6.30 M(+24.0%) |
| Sep 2002 | - | $5.08 M(+26.2%) |
| Jun 2002 | - | $4.03 M(+7.3%) |
| Mar 2002 | - | $3.75 M(+53.7%) |
| Dec 2001 | $2.44 M(-25.6%) | $2.44 M(+116.3%) |
| Sep 2001 | - | $1.13 M(-28.0%) |
| Jun 2001 | - | $1.57 M(-34.3%) |
| Mar 2001 | - | $2.38 M(-27.3%) |
| Dec 2000 | $3.28 M(+115.3%) | $3.28 M(+58.7%) |
| Sep 2000 | - | $2.07 M(+16.9%) |
| Jun 2000 | - | $1.77 M(-1.1%) |
| Mar 2000 | - | $1.79 M(+17.4%) |
| Dec 1999 | $1.52 M(+52.4%) | $1.52 M(+154.0%) |
| Sep 1999 | - | $600.00 K(-45.5%) |
| Jun 1999 | - | $1.10 M(-15.4%) |
| Mar 1999 | - | $1.30 M(+30.0%) |
| Dec 1998 | $1.00 M(+25.0%) | $1.00 M(+11.1%) |
| Sep 1998 | - | $900.00 K(-25.0%) |
| Jun 1998 | - | $1.20 M(+9.1%) |
| Mar 1998 | - | $1.10 M(+37.5%) |
| Dec 1997 | $800.00 K(+166.7%) | $800.00 K(-42.9%) |
| Sep 1997 | - | $1.40 M(+7.7%) |
| Jun 1997 | - | $1.30 M(0.0%) |
| Mar 1997 | - | $1.30 M(+333.3%) |
| Dec 1996 | $300.00 K(-25.0%) | $300.00 K(0.0%) |
| Sep 1996 | - | $300.00 K(0.0%) |
| Jun 1996 | - | $300.00 K(-25.0%) |
| Mar 1996 | - | $400.00 K(0.0%) |
| Dec 1995 | $400.00 K | $400.00 K(-88.2%) |
| Jun 1995 | - | $3.40 M(+61.9%) |
| Mar 1995 | - | $2.10 M |
FAQ
- What is Windtree Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Windtree Therapeutics?
- What is Windtree Therapeutics annual total liabilities year-on-year change?
- What is Windtree Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly total liabilities year-on-year change?
What is Windtree Therapeutics annual total liabilities?
The current annual total liabilities of WINT is $29.02 M
What is the all time high annual total liabilities for Windtree Therapeutics?
Windtree Therapeutics all-time high annual total liabilities is $51.28 M
What is Windtree Therapeutics annual total liabilities year-on-year change?
Over the past year, WINT annual total liabilities has changed by +$1.07 M (+3.84%)
What is Windtree Therapeutics quarterly total liabilities?
The current quarterly total liabilities of WINT is $26.04 M
What is the all time high quarterly total liabilities for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly total liabilities is $51.28 M
What is Windtree Therapeutics quarterly total liabilities year-on-year change?
Over the past year, WINT quarterly total liabilities has changed by -$2.53 M (-8.87%)